STORZ MEDICAL

What STORZ MEDICAL does

STORZ MEDICAL AG is a Switzerland-based medical device company founded in 1987 and headquartered in Tägerwilen, operating as an independent partner company of the KARL STORZ Group. The company develops shock wave therapy and laser-based medical technologies, with a portfolio spanning urology (lithotripsy), physiotherapy and musculoskeletal treatment, and — most recently — neurorehabilitation. Its flagship product is the NEUROLITH System, a CE-marked transcranial pulse stimulation (TPS) device that uses focused shock waves to non-invasively stimulate neural tissue, targeting Alzheimer's disease and other neurological conditions. The company serves hospitals, neurology clinics, neurorehabilitation centers, urology departments, and physiotherapy clinics, with a horizontal segmentation approach across three primary use-case verticals.

The company monetizes through two principal revenue streams: sale of proprietary medical hardware (the NEUROLITH system and related shock wave equipment) and technology licensing of TPS technology and CE-marked systems to clinical partners. Pricing is quote-based and not publicly disclosed, consistent with enterprise capital equipment sales. Go-to-market is enterprise field sales, with direct engagement of healthcare institutions and strategic clinical partnerships used to enter specific regional markets — exemplified by the December 2025 partnership with Robotimize to deploy TPS technology at Malaysian healthcare institutions. Distribution is direct-to-institution, supplemented by regional strategic alliances.

The company has 51-100 employees, no public listing, and no disclosed funding rounds. No M&A activity, leadership changes, or restructuring events are documented in the available sources. AI and software capabilities are not a stated component of the technology stack, which remains anchored in physical shock wave and laser engineering.

Name

STORZ MEDICAL

Website

https://storzmedical.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

51–100 employees

Short description

STORZ MEDICAL AG, founded in 1987 in Switzerland, develops shock wave and laser-based medical devices including the CE-marked NEUROLITH transcranial pulse stimulation system, serving hospitals, neurology clinics, and physiotherapy centers for Alzheimer's, neurorehabilitation, and urological applications.

Ownership category

akta.pro rank

Product category

Medical Devices — Shock Wave Therapy and Lithotripsy

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)

akta.pro secondary industry

Kidney Stone Management & Lithotripsy Devices (HLAHAKAI)

Keywords

• Shock wave therapy
• Medical device manufacturing
• Transcranial pulse stimulation
• Lithotripsy devices
• Neurorehabilitation equipment

Headquarters

HQ city

Tägerwilen

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

1. Medical Device Sales: Sale of proprietary medical devices including the NEUROLITH system and related equipment for shock wave therapy applications in hospitals and specialty clinics.
2. Technology Licensing: Licensing of TPS technology and CE-marked systems to clinical partners for neurorehabilitation applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

STORZ MEDICAL designs, manufactures, and sells medical devices based on shock wave and laser technology for clinical use. Its flagship offering is the CE-marked NEUROLITH® System for transcranial pulse stimulation (TPS) in the treatment of Alzheimer's disease and other neurological conditions. The portfolio also includes shock wave therapy systems for physiotherapy/musculoskeletal care and lithotripsy devices for urological stone treatment.

Product overview

STORZ MEDICAL offers medical devices focused on shock wave therapy and neurorehabilitation. The company provides the NEUROLITH® System, a CE-marked transcranial pulse stimulation technology designed for treating Alzheimer's and neurological conditions. Their portfolio includes shock wave therapy devices used in physiotherapy and related medical applications.

Differentiator

Problem solved

Functional benefit

Products and services

• NEUROLITH® System CE-marked transcranial pulse stimulation (TPS) system that delivers focused shock waves to target brain regions for non-invasive treatment of Alzheimer's disease and other neurological/neurodegenerative conditions; designed for hospitals, neurology clinics, and neurorehabilitation centers.
• Shock Wave Therapy Systems Focused shock wave therapy devices used by physiotherapy clinics and rehabilitation centers for non-invasive treatment of musculoskeletal conditions; addresses demand in a market growing at 12.3% CAGR (2024–2029).
• Rigid Endoscopic Lithotripsy Devices

Quantifiable outcome

• Expands neurorehabilitation options for aging populations with neurodegenerative conditions

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core and minor.

• RobotimizecoreStrategic or Co-development Partner · 16 December 2025Robotimize and Storz Medical partnered to introduce Transcranial Pulse Stimulation (TPS) technology in Malaysia through strategic clinical engagement at Malaysian healthcare institutions. The CE-marked NEUROLITH system expands neurorehabilitation options for aging populations and addresses clinical demands for neurodegenerative care. The initiative aims to enhance evidence-based neuromodulation access and integrate the technology into comprehensive neurological care practices in Malaysia.
• Well Lead MedicalminorStrategic or Co-development PartnerKarl Storz partnership with Well Lead Medical in the rigid endoscopic lithotripsy devices market. Key companies are investing in research and strategic partnerships to enhance product offerings in the growing lithotripsy devices market expected to reach $6.11 billion by 2030.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• EDAP TMS: French medical device company specializing in shock wave and HIFU-based lithotripsy and urology devices, overlapping directly with Storz Medical's lithotripsy and shock wave therapy portfolio across hospitals and urology departments.
• Dornier MedTech: Pioneer in focused extracorporeal shock wave lithotripsy for urinary stone treatment and shock wave orthopedics, with overlapping R&D and clinical indications to Storz Medical's shock wave technology.
• BTL Industries: Manufactures focused and radial shock wave therapy devices used by physiotherapy, orthopedics and aesthetics clinics, directly competing with Storz Medical's musculoskeletal shock wave portfolio.
• Zimmer MedizinSysteme: German device maker of shock wave therapy, physiotherapy and aesthetic systems, closely overlapping with Storz Medical's shock wave and laser-based medical technology offerings in European clinics.
• Richard Wolf: German manufacturer of endoscopy and urology/lithotripsy systems widely deployed in stone treatment centers, directly comparable to Storz Medical's lithotripsy and urology device portfolio.

Broad incumbents

• Medtronic: Global leader in neuromodulation (DBS, SCS, VNS) and broader surgical and rehabilitation therapies; comparable to Storz Medical's TPS/neurology efforts as a deep-pocketed incumbent expanding into adjacent neuromodulation indications.
• Boston Scientific: Diversified neuromodulation player (Vercise DBS, Precision SCS) with significant R&D and clinical evidence capabilities in brain stimulation; competes with Storz Medical's ambitions in neurological intervention.
• Olympus: Broad endoscopic and urology device manufacturer with lithotripsy solutions; overlaps with Storz Medical in hospital urology and surgical device markets and serves as a benchmark for distribution scale.
• DJO Global / Chattanooga: Rehabilitation and physiotherapy equipment provider including shock wave therapy platforms, comparable to Storz Medical's physiotherapy center customer base and musculoskeletal shock wave products.
• Siemens Healthineers: Diversified medical technology company with therapy and surgical solutions including image-guided interventions; adjacent incumbent offering that targets the same hospitals and specialty clinics served by Storz Medical.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/storzmedical

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STORZ MEDICAL